```html

Cold‑Induced Bronchospasm

What is Cold‑Induced Bronchospasm?

Cold‑induced bronchospasm (CIB) is a sudden narrowing of the airways that occurs when a person inhales cold, dry air. The constriction of the bronchial smooth muscle limits airflow, leading to wheezing, coughing, and shortness of breath. CIB is most commonly seen in people who have underlying airway hyper‑responsiveness, such as asthma, but it can also affect otherwise healthy individuals who are exposed to very low temperatures (often below 10 °C/50 °F) during exercise or outdoor activities.

Unlike a typical asthma attack that may be triggered by allergens or viral infections, CIB is specifically precipitated by temperature‑related irritation of the airway lining. The reflex is mediated by the vagus nerve and the release of inflammatory mediators like histamine, leukotrienes, and prostaglandins, which cause the bronchial smooth muscle to contract.

Because the trigger is environmental, CIB can be unpredictable and may occur in anyone who suddenly switches from a warm indoor environment to a cold outdoor setting, engages in high‑intensity outdoor exercise in winter, or breathes cold air through a mouth‑piece (e.g., during scuba diving or high‑altitude climbing).

Common Causes

The following conditions and situations are frequently associated with cold‑induced bronchospasm:

• Exercise‑induced bronchoconstriction (EIB): Physical activity in cold weather increases ventilation, drawing more cold air into the lungs.
• Asthma: Individuals with asthma have hyper‑responsive airways that react more readily to temperature changes.
• Allergic rhinitis (hay fever): Nasal congestion forces mouth breathing, delivering colder air directly to the lower airway.
• Upper respiratory infections: Viral or bacterial infections inflame the airway, lowering the threshold for cold‑triggered spasms.
• Occupational exposure: Jobs that involve repetitive cold‑air inhalation (e.g., freezer workers, ski‑patrol, outdoor construction).
• Chronic obstructive pulmonary disease (COPD): Damaged airways may react similarly to cold air, especially during exacerbations.
• Bronchiectasis: Dilated airways are more sensitive to irritants, including cold, dry air.
• High‑altitude exposure: Lower humidity and temperature at altitude increase the risk of bronchospasm.
• Use of certain medications: Beta‑blockers and non‑selective antihistamines can worsen airway reactivity.
• Underlying genetic predisposition: Certain polymorphisms (e.g., ADAM33, IL33) are linked to heightened airway responsiveness to temperature changes.

Associated Symptoms

Cold‑induced bronchospasm often presents with a cluster of respiratory symptoms that develop within minutes of exposure to cold air. Commonly reported signs include:

• Wheezing (high‑pitched whistling sound during exhalation)
• Chest tightness or “pressure” sensation
• Dry, hacking cough
• Shortness of breath or rapid breathing (tachypnea)
• Difficulty speaking full sentences
• Increased mucus production (less common than in infectious bronchitis)
• Feelings of fatigue after a bout of coughing or wheezing

Symptoms typically improve once the individual re‑warms the airway—by moving indoors, covering the mouth with a scarf, or using a humidifier—but may recur if cold exposure continues.

When to See a Doctor

Most episodes of CIB are self‑limited, yet medical evaluation is essential when any of the following occur:

• Symptoms persist longer than 30 minutes after returning to a warm environment.
• Wheezing or shortness of breath worsens despite using a rescue inhaler (short‑acting β2‑agonist).
• Repeated episodes (≥2 times per month) interfere with work, school, or exercise.
• You have a personal or family history of asthma, COPD, or other chronic lung disease.
• You develop fever, chest pain, or a productive cough (could indicate infection).
• You notice a decline in overall lung function (e.g., needing higher doses of medication).

Prompt evaluation can prevent progression to a severe asthma attack and help identify underlying conditions that may need long‑term management.

Diagnosis

Diagnosing cold‑induced bronchospasm involves a combination of clinical history, physical examination, and objective testing.

1. Detailed History

• Timing of symptoms relative to cold exposure.
• Intensity and duration of activity (e.g., running, skiing).
• Previous diagnosis of asthma, allergies, or respiratory disease.
• Medication use (especially inhaled corticosteroids or β‑agonists).
• Occupational or recreational exposures to cold air.

2. Physical Examination

• Listen for wheezes, especially during forced exhalation.
• Assess respiratory rate and oxygen saturation (pulse oximetry).
• Check for signs of allergic rhinitis (nasal congestion, post‑nasal drip).

3. Pulmonary Function Tests (PFTs)

• Spirometry: Measures forced expiratory volume in 1 second (FEV₁). A ≥10‑15 % drop after a cold‑air challenge supports the diagnosis.
• Bronchial Provocation Test: A standardized cold‑air challenge (inhalation of air at 4‑10 °C for ~2 minutes) while monitoring lung function.
• Peak Expiratory Flow (PEF): Patients can record PEF before and after exposure; a ≥20 % fall is significant.

4. Additional Tests (if needed)

• Allergy skin testing or serum IgE to rule out allergic asthma.
• Chest X‑ray if persistent cough suggests infection or other pathology.
• Exhaled nitric oxide (FeNO) to assess airway inflammation.

Treatment Options

Management of cold‑induced bronchospasm focuses on rapid relief of acute symptoms and long‑term strategies to reduce frequency.

Acute (Rescue) Therapy

• Short‑acting β2‑agonists (SABA): Albuterol or levalbuterol inhalers provide quick bronchodilation (onset 5‑15 minutes). Use 1–2 puffs every 4–6 hours as needed.
• Anticholinergics: Ipratropium bromide (AeroEclipse) can be added for additional bronchodilation, especially in those with COPD.
• Systemic Corticosteroids: Prednisone 40‑60 mg for 5‑7 days may be prescribed if symptoms do not improve with SABA within 30 minutes.

Long‑Term Control

• Inhaled Corticosteroids (ICS): Low‑dose budesonide or fluticasone reduces airway inflammation and lowers the threshold for cold‑air triggers.
• Long‑acting β2‑agonists (LABA) + ICS: For patients requiring >2 rescue inhalations per week.
• Lekotriene Receptor Antagonists (LTRAs): Montelukast can help especially in those with allergic components.
• Mast‑cell stabilizers (e.g., cromolyn sodium): Inhaled form taken before exposure may blunt bronchoconstriction.

Home and Lifestyle Measures

• Carry a rescue inhaler at all times during cold weather activities.
• Warm the inhaled air by breathing through a scarf, mask, or a “snow mask” (fabric covering that humidifies and warms air).
• Pre‑medicate 10‑15 minutes before exercise with a SABA (e.g., albuterol 2 puffs).
• Use a portable humidifier or vaporizer when indoors in winter to keep ambient air moist.
• Avoid smoking and second‑hand smoke, which magnify airway hyper‑responsiveness.
• Maintain optimal control of any underlying asthma or COPD with regular follow‑up.

Prevention Tips

Because CIB is triggered by environmental conditions, many preventive steps are practical and inexpensive.

• Layered Clothing: Wear a breathable, moisture‑wicking base layer and a wind‑proof outer layer to reduce heat loss.
• Mask or Scarf: Cover the mouth and nose with a scarf, balaclava, or a specialized cold‑air mask to warm and humidify each breath.
• Gradual Warm‑Up: Begin outdoor activity at a slower pace, allowing the airways to adapt before intense exertion.
• Pre‑Exercise Inhaler Use: Administer a short‑acting β2‑agonist 10‑15 minutes before starting cold‑weather exercise.
• Hydration: Adequate fluid intake keeps airway mucus thin, reducing irritation.
• Indoor Alternatives: When temperatures drop below 0 °C (32 °F) or humidity is <30 %, consider indoor training (treadmill, stationary bike).
• Environmental Monitoring: Check local weather forecasts; avoid high‑intensity outdoor workouts on days with extreme cold or wind chill.
• Medication Adherence: Take prescribed controller inhalers daily, even when asymptomatic.
• Vaccinations: Annual influenza vaccine and pneumococcal vaccination lower the risk of respiratory infections that can exacerbate CIB.

Emergency Warning Signs

---

Key Take‑aways

• Cold‑induced bronchospasm is a reversible narrowing of the airways triggered by inhaling cold, dry air.
• It commonly occurs in people with asthma, exercise‑induced bronchoconstriction, allergic rhinitis, or chronic lung disease.
• Typical symptoms are wheezing, chest tightness, cough, and shortness of breath that improve with warming and bronchodilators.
• Diagnosis is based on a focused history, physical exam, and objective lung‑function testing (spirometry or cold‑air challenge).
• Acute treatment uses short‑acting β2‑agonists; long‑term control relies on inhaled corticosteroids and, when needed, LABA or leukotriene modifiers.
• Prevention centers on warming and humidifying inspired air, pre‑medicating before exercise, and maintaining good control of any underlying respiratory disease.
• Immediate medical attention is required for severe or worsening symptoms, especially signs of hypoxia or cardiovascular compromise.

References

1. Mayo Clinic. “Exercise‑induced asthma.” Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. “Asthma and Cold Weather.” 2022. https://www.cdc.gov
3. National Heart, Lung, and Blood Institute (NHLBI). “Guidelines for the Diagnosis and Management of Asthma.” 2020. https://www.nhlbi.nih.gov
4. World Health Organization. “Air quality and health.” 2021. https://www.who.int
5. Cleveland Clinic. “Cold Weather and Asthma – How to Stay Safe.” 2023. https://my.clevelandclinic.org
6. American Thoracic Society. “Standardized Exercise Challenge Testing in Adults.” *American Journal of Respiratory and Critical Care Medicine*, 2020;202(5):629‑641. DOI:10.1164/rccm.202001‑0146ST.

```